FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

346672000: Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3682655012 Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3682657016 Isoniazid 50 mg and pyrazinamide 300 mg and rifampin 120 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3682658014 Isoniazid 50 mg and pyrazinamide 300 mg and rifampicin 120 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Plays role Antitubercular therapeutic role true Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Rifampin true Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Pyrazinamide (substance) true Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Pyrazinamide (substance) true Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Rifampin true Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) médicament contenant rifampicine et isoniazide et pyrazinamide false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Isoniazid (substance) false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Pyrazinamide (substance) false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Rifampin false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Hydrazine false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a une forme pharmaceutique (attribut) comprimé false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Bactericide false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a une forme pharmaceutique (attribut) Oral tablet true Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Product containing rifampicin in oral dose form (medicinal product form) false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Isoniazid-containing product in oral dose form false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) false Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Isoniazid (substance) false Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Isoniazid (substance) false Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 50 (qualifier value) false Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Pyrazinamide (substance) false Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 300 (qualifier value) false Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Isoniazid (substance) true Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 50 (qualifier value) false Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Rifampin false Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Rifampin false Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 120 (qualifier value) false Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Pyrazinamide (substance) false Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Pyrazinamide (substance) false Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 300 (qualifier value) false Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Isoniazid (substance) true Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Pyrazinamide (substance) false Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Rifampin false Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient trois false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start